Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Walker

Showing results (381-390 of 490) with videos related to

Pageof 49
Sort By:
Journal of Virology|January 1, 2009
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognitionToshiyuki Miura, Mark A Brockman, Arne Schneidewind, et al.
Journal of Virology|May 8, 2009
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceDiana M Brainard, Edward Seung, Nicole Frahm, et al.
The Journal of Clinical Investigation|March 16, 2011
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Huabiao Chen, Chun Li, Jinghe Huang, et al.
Nature Genetics|November 26, 2009
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-CRasmi Thomas, Richard Apps, Ying Qi, et al.
Cell|July 15, 2021
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecovirusesAnusha Nathan, Elizabeth J Rossin, Clarety Kaseke, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Cell Host & Microbe|October 23, 2012
A Blueprint for HIV Vaccine DiscoveryDennis R Burton, Rafi Ahmed, Dan H Barouch, et al.
Cell|April 1, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Journal of Virology|May 28, 2010
Impaired replication capacity of acute/early viruses in persons who become HIV controllersToshiyuki Miura, Zabrina L Brumme, Mark A Brockman, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
Pageof 49

Showing results (381-390 of 490) with videos related to

Sort By:
Pageof 49
Journal of Virology|January 1, 2009
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognitionToshiyuki Miura, Mark A Brockman, Arne Schneidewind, et al.
Journal of Virology|May 8, 2009
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceDiana M Brainard, Edward Seung, Nicole Frahm, et al.
The Journal of Clinical Investigation|March 16, 2011
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Huabiao Chen, Chun Li, Jinghe Huang, et al.
Nature Genetics|November 26, 2009
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-CRasmi Thomas, Richard Apps, Ying Qi, et al.
Cell|July 15, 2021
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecovirusesAnusha Nathan, Elizabeth J Rossin, Clarety Kaseke, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Cell Host & Microbe|October 23, 2012
A Blueprint for HIV Vaccine DiscoveryDennis R Burton, Rafi Ahmed, Dan H Barouch, et al.
Cell|April 1, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Journal of Virology|May 28, 2010
Impaired replication capacity of acute/early viruses in persons who become HIV controllersToshiyuki Miura, Zabrina L Brumme, Mark A Brockman, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
Pageof 49